Qiagen's shares rose 8 percent for the five-day trading period ended Tuesday, leading the 13 firms that posted gains in the BCW Index. Qiagen reported a 9-percent increase in fourth-quarter revenues on Monday after the close of the market. Its shares gained 5.4 percent in the first full day of trading after the results were released. Only three firms posted declines in their stock for the tracking period, led by Invitrogen, which fell 1.3 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.